The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients

被引:140
作者
Yuan, Jing [1 ]
Zou, Rougrong [1 ]
Zeng, Lijiao [1 ]
Kou, Shanglong [1 ]
Lan, Jianfeng [1 ]
Li, Xiaohe [1 ]
Liang, Yanhua [1 ]
Ding, Xiaoyan [1 ]
Tan, Guoyu [1 ]
Tang, Shenghong [1 ]
Liu, Lei [1 ]
Liu, Yingxia [1 ]
Pan, Yanchao [1 ]
Wang, Zhaoqin [1 ]
机构
[1] Shenzhen Third Peoples Hosp, Diag & Treatment Infect Dis Res Lab, Shenzhen 518112, Peoples R China
关键词
COVID-19; Clearance ratio; LDH; CK; RESPIRATORY SYNDROME CORONAVIRUS; SARS; RIBAVIRIN;
D O I
10.1007/s00011-020-01342-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective This study aims to evaluate the correlation between viral clearance and blood biochemical index of 94 discharged patients with COVID-19 infection in Shenzhen Third People's Hospital, enrolled from Jan 5 to Feb 13, 2020. Methods The clinical and laboratory findings were extracted from the electronic medical records of the patients. The data were analysed and reviewed by a trained team of physicians. Information on clinical signs and symptoms, medical treatment, virus clearance, and laboratory parameters including interleukin 6 (IL-6) and C-reactive protein were collected. Results COVID-19 mRNA clearance ratio was identified significantly correlated with the decline of serum creatine kinase (CK) and lactate dehydrogenase (LDH) levels. Furthermore, COVID-19 mRNA clearance time was positively correlated with the length of hospital stay in patients treated with either IFN-alpha + lopinavir/ritonavir or IFN-alpha + lopinavir/ritonavir + ribavirin. Conclusions Therapeutic regimens of IFN-alpha + lopinavir/ritonavir and IFN-alpha + lopinavir/ritonavir + ribavirin might be beneficial for treatment of COVID-19. Serum LDH or CK decline may predict a favorable response to treatment of COVID-19 infection.
引用
收藏
页码:599 / 606
页数:8
相关论文
共 19 条
  • [1] [Anonymous], JAMA
  • [2] Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection
    Arabi, Yaseen M.
    Arifi, Ahmed A.
    Balkhy, Hanan H.
    Najm, Hani
    Aldawood, Abdulaziz S.
    Ghabashi, Alaa
    Hawa, Hassan
    Alothman, Adel
    Khaldi, Abdulaziz
    Al Raiy, Basel
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 160 (06) : 389 - +
  • [3] A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
    Chan, Jasper Fuk-Woo
    Yuan, Shuofeng
    Kok, Kin-Hang
    To, Kelvin Kai-Wang
    Chu, Hin
    Yang, Jin
    Xing, Fanfan
    Liu, Jieling
    Yip, Cyril Chik-Yan
    Poon, Rosana Wing-Shan
    Tsoi, Hoi-Wah
    Lo, Simon Kam-Fai
    Chan, Kwok-Hung
    Poon, Vincent Kwok-Man
    Chan, Wan-Mui
    Ip, Jonathan Daniel
    Cai, Jian-Piao
    Cheng, Vincent Chi-Chung
    Chen, Honglin
    Hui, Christopher Kim-Ming
    Yuen, Kwok-Yung
    [J]. LANCET, 2020, 395 (10223) : 514 - 523
  • [4] IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
    Channappanavar, Rudragouda
    Fehr, Anthony R.
    Zheng, Jian
    Wohlford-Lenane, Christine
    Abrahante, Juan E.
    Mack, Matthias
    Sompallae, Ramakrishna
    McCray, Paul B., Jr.
    Meyerholz, David K.
    Perlman, Stanley
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (09) : 3625 - 3639
  • [5] Treatment of SARS with human interferons
    Cinatl, J
    Morgenstern, B
    Bauer, G
    Chandra, P
    Rabenau, H
    Doerr, HW
    [J]. LANCET, 2003, 362 (9380) : 293 - 294
  • [6] SARS and MERS: recent insights into emerging coronaviruses
    de Wit, Emmie
    van Doremalen, Neeltje
    Falzarano, Darryl
    Munster, Vincent J.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2016, 14 (08) : 523 - 534
  • [7] Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies
    Dyall J.
    Gross R.
    Kindrachuk J.
    Johnson R.F.
    Olinger G.G., Jr.
    Hensley L.E.
    Frieman M.B.
    Jahrling P.B.
    [J]. Drugs, 2017, 77 (18) : 1935 - 1966
  • [8] Huang CL, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30211-7, 10.1016/S0140-6736(20)30183-5]
  • [9] A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome
    Jiang, Shibo
    Xia, Shuai
    Ying, Tianlei
    Lu, Lu
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (05) : 554 - 554
  • [10] Clinical and Laboratory Findings of the First Imported Case of Middle East Respiratory Syndrome Coronavirus to the United States
    Kapoor, Minal
    Pringle, Kimberly
    Kumar, Alan
    Dearth, Stephanie
    Liu, Lixia
    Lovchik, Judith
    Perez, Omar
    Pontones, Pam
    Richards, Shawn
    Yeadon-Fagbohun, Jaime
    Breakwell, Lucy
    Chea, Nora
    Cohen, Nicole J.
    Schneider, Eileen
    Erdman, Dean
    Haynes, Lia
    Pallansch, Mark
    Tao, Ying
    Tong, Suxiang
    Gerber, Susan
    Swerdlow, David
    Feikin, Daniel R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (11) : 1511 - 1518